Dynavax Technologies Corp (NAS:DVAX)
$ 13 -0.03 (-0.23%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Q2 2023 Dynavax Technologies Corp Earnings Call Transcript

Aug 03, 2023 / 08:30PM GMT
Release Date Price: $13.39 (-1.11%)
Operator

Good day, ladies and gentlemen, and welcome to Dynavax Technologies, Second Quarter 2023 Financial Results. As a reminder, this conference is being recorded. (Operator Instructions) I would now like to turn the call over to Paul Cox, Vice President, Investor Relations and Corporate Communications. You may begin.

Paul Cox
Dynavax Technologies Corporation - VP of IR & Corporate Communications

Thank you all for participating in today's call. Joining me today from Dynavax are Ryan Spencer, Chief Executive Officer; Donn Casale, Chief Commercial Officer; Rob Janssen, Chief Medical Officer; and Kelly MacDonald, Chief Financial Officer.

Earlier today, Dynavax released financial results for the second quarter ended June 30, 2023. Copies of the press release and a supplementary slide presentation are available on Dynavax' website. Before we begin, I advise you that we will be making forward-looking statements today based on our current expectations and beliefs, including, but not limited to, potential market sizes, market segmentation, effective marketing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot